|
Today's Headlines
Low-risk Medicare patients entering home healthcare and receiving a telephonic medication therapy management consultation by a pharmacist were 3 times less likely to be hospitalized within the next 2 months, while those at greater risk saw no benefit, according to a study in Health Services Research. » Full article
|
|
Progress has been made in the effort to eliminate infections that commonly threaten hospital patients, but more work is needed to improve patient safety, according to 2 reports released by the Centers for Disease Control and Prevention. » Full article
|
Continuing Education
This month's article is the third in a new year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. This goal of this month's activity is to review nonpharmacologic treatment strategies relevant to medication therapy management of hypertension and introduce drug therapy considerations in geriatric patients with hypertension.
To read and print the article with TEST QUESTIONS, click here.
To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at
www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career.
|
|
|
EDITOR'S PICK
Farxiga (dapagliflozin), in tablets for oral use, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that was approved by FDA in January 2014 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. » Full article
|
|
Like
Tweet
